Early research (Phase 1)Temporarily pausedNCT03120130What this trial is testingStudy of Amblyomin-X in Advanced Solid TumorWho this might be right forAdvanced Cancer União Química Farmacêutica Nacional S/A 24
Early research (Phase 1)Study completedNCT00677105What this trial is testingA Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma.Who this might be right forLymphomaNeoplasms Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 92
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07389239What this trial is testingA Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.Who this might be right forOvarian CancerAdvanced Malignant Solid Tumor University of Chicago 24
Early research (Phase 1)Active Not RecruitingNCT01303341What this trial is testingRiluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or MelanomaWho this might be right forAdvanced Malignant Solid NeoplasmRecurrent MelanomaRefractory Malignant Solid Neoplasm+5 more National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT00996957What this trial is testingStudy of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple MyelomaWho this might be right forAdvanced Solid TumorsMultiple Myeloma Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 37
Early research (Phase 1)Study completedNCT02029729What this trial is testingRTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVERWho this might be right forMetastatic or Incurable Non-small Cell Lung CancerRelapsed, Refractory Melanoma Biogen 11
Testing effectiveness (Phase 2)Looking for participantsNCT06911333What this trial is testingAD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid TumorsWho this might be right forSolid Tumor, AdultTumor, SolidSolid Tumor+4 more Avelos Therapeutics Inc. 36
Early research (Phase 1)Looking for participantsNCT05111561What this trial is testingTesting the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast CancerWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm+2 more National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT00124605What this trial is testingArsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple MyelomaWho this might be right forRefractory Multiple MyelomaUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT03985072What this trial is testingStudy With Andes-1537 in Patients With Specific Types of Advanced Solid TumorWho this might be right forTumor, SolidGall Bladder CancerCervical Cancer+3 more Andes Biotechnologies 67
Early research (Phase 1)Study completedNCT00694356What this trial is testingStudy of Dalotuzumab (MK-0646) in Adults With Solid Tumors (MK-0646-009)Who this might be right forNeoplasm Merck Sharp & Dohme LLC 15
Early research (Phase 1)Study completedNCT00410553What this trial is testingEribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by SurgeryWho this might be right forAdult Solid NeoplasmRecurrent Ovarian CarcinomaRecurrent Uterine Corpus Carcinoma+4 more National Cancer Institute (NCI) 45
Early research (Phase 1)Ended earlyNCT01908413What this trial is testingPhase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or LymphomaWho this might be right forLymphoma Curis, Inc. 23
Early research (Phase 1)Looking for participantsNCT05098210What this trial is testingPersonalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more Fred Hutchinson Cancer Center 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT03678883What this trial is testing9-ING-41 in Patients With Advanced CancersWho this might be right forCancerPancreatic CancerSarcoma+22 more Actuate Therapeutics Inc. 350
Early research (Phase 1)Study completedNCT01404390What this trial is testingJapanese BAY80-6946 Monotherapy Phase I StudyWho this might be right forNeoplasms Bayer 10
Early research (Phase 1)Study completedNCT00019513What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasWho this might be right forColorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Early research (Phase 1)Study completedNCT03788603What this trial is testingRogaratinib (BAY1163877) in Chinese PatientsWho this might be right forNeoplasms Bayer 1
Early research (Phase 1)Study completedNCT00458731What this trial is testingBevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+59 more National Cancer Institute (NCI) 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT04725474What this trial is testingFirst-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER)Who this might be right forSolid Tumor, Adult CatalYm GmbH 199